A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines
| Status: | Completed |
|---|---|
| Conditions: | Migraine Headaches |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/21/2016 |
| Start Date: | May 2013 |
| End Date: | May 2014 |
This study will evaluate the effectiveness and benefit of treatment with onabotulinumtoxinA
in Chronic Migraine patients who have received a minimum of 7 treatment cycles.
in Chronic Migraine patients who have received a minimum of 7 treatment cycles.
Inclusion Criteria:
- 15 or more headache days over a 30 day period
- A minimum of 7 treatment cycles with onabotulinumtoxinA
Exclusion Criteria:
- Any treatment cycle dose of onabotulinumtoxinA greater than 200 units
We found this trial at
1
site
Click here to add this to my saved trials
